About
About YanAn Bicon Pharmaceutical Listed Company
YanAn Bicon Pharmaceutical Listed Company researches and develops, produces, and sells pharmaceutical intermediates, pesticide intermediates, and new energy and materials products in China. It offers pharmaceutical intermediate products, including sodium triclopyridine, 5,5-dimethylhydantoin, benzaldehyde, etc.; and Chinese herbal medicines. The company also provides lithium hexafluorophosphate; and ultra-high molecular weight polyethylene fibers for use in anti-cut gloves, home textiles, cables, fishing nets, fishing lines, outdoor sports wear products, bulletproof helmets, stab-proof clothing, etc., as well as military industry, aerospace composite materials, ocean-going ships, naval ship ropes, ocean fishing trawls, deep-sea anti-wind wave cages and sporting goods equipment, construction engineering reinforcement, and performance composite materials. In addition, it is involved in the freight warehousing and leasing; cultivation and sales of medicinal herbs; e-commerce business; real estate development; transportation; postal industry; cargo freight; textile industry; and chemical fiber manufacturing. The company was formerly known as JiangSu Bicon Pharmaceutical Listed Company and changed its name to YanAn Bicon Pharmaceutical Listed Company in October 2018. YanAn Bicon Pharmaceutical Listed Company was founded in 2007 and is headquartered in Xi'an, China.
Visit company website
5 years, 5 months ago
YanAn Bicon Pharmaceutical Listed Company is currently in a long term uptrend where the price is trading 12.9% above its 200 day moving average.
From a valuation standpoint, the stock is 80.1% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 0.8.
YanAn Bicon Pharmaceutical Listed Company's total revenue sank by 30.6% to $2B since the same quarter in the previous year.
Its net income has dropped by 117.7% to $-23M since the same quarter in the previous year.
Finally, its free cash flow fell by 114.5% to $-149M since the same quarter in the previous year.
Based on the above factors, YanAn Bicon Pharmaceutical Listed Company gets an overall score of 2/5.